Yong Tai to collaborate with Chinese company in Covid-19 vaccine development, distribution in Malaysia
Yong Tai will be SZKT's partner in Malaysia to conduct Phase III clinical trials and exclusive commercialisation of the vaccine.
Yong Tai will be SZKT's partner in Malaysia to conduct Phase III clinical trials and exclusive commercialisation of the vaccine.
To date, 381 clusters have been reported. Meanwhile, 193 clusters have been declared ended including four clusters today, namely the Bandaran, Kolong and Ramai-ramai clusters in Sabah, and the Sentral cluster involving Selangor and Kuala Lumpur.
There are now 1,510 active cases — meaning those who carry high transmission risks — under this cluster, while 3,646 patients have recovered, with no deaths.
The CMCO for Selangor, Putrajaya, Kuala Lumpur, Sabah, Labuan, Kelantan, Perak, Penang and Negeri Sembilan is currently scheduled to end on Sunday (Dec 6).
Tan Sri Dr Noor Hisham Abdullah said the Klang Valley — comprising Selangor, Kuala Lumpur and Putrajaya — recorded 578 cases or 50.7% of total new infections.
In a bourse filing today, Yong Tai said 89,300 shares will be listed on Dec 8 following the conversion, which will see its issued share capital rise to 1.04 billion shares or RM456.8 million.
Out of the 59 assemblypersons, 10 voted for the motion, 48 voted against, and one abstained or cast a spoiled ballot.
Lim, who holds an 11.07% stake in Tropicana, is also the chairman and founder of Top Glove, in which he controls 25.68%.
The hearing was supposed to resume today.
The Monsoon cluster — the lone cluster identified in Petaling Jaya, Selangor — has 19 confirmed cases.